Patients treated with ALYGLO™ receive one infusion every three to four weeks administered by a nurse either at home or at an infusion center. GC Biopharma selected AOM Infusion as a partner ...

DALLAS, January 13, 2025--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured ... The nationally accredited home infusion teams at AIC collaborate closely ...

ALYGLO is a liquid solution containing 10% immunoglobulin G (100 mg/mL) for intravenous infusion, manufactured from pooled human plasma from US donors. The manufacturing process includes three ...

GC Biopharma plans to market Alyglo in the United States through its American subsidiary, GC Biopharma USA, by the latter half of next year. Alyglo, an intravenous immune globulin, is a treatment for ...

July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA, Inc. as a limited distribution partner to provide ALYGLO ...